All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.

The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Anton Hagenbeek | EHA 2018 | Relevant findings of the RELEVANCE phase III study

23rd Congress of European Hematology Association, 14-17 June 2018, Stockholm, Sweden
Anton Hagenbeek
Amsterdam University Medical Center, Amsterdam, NL

Interview topic: Relevant findings of the RELEVANCE phase III study in first-line treatment of patients with FL

Relevant findings of the RELEVANCE phase III study

Share: